Literature DB >> 16151913

Dihydropyrimidine dehydrogenase deficiency presenting at birth.

N A Al-Sanna'a1, A B P Van Kuilenburg, T M Atrak, M A Abdul-Jabbar, A H Van Gennip.   

Abstract

Dihydropyrimidine dehydrogenase (DPD) deficiency (McKusick 274270) is a clinically heterogeneous autosomal recessive disorder of pyrimidine metabolism. DPD is the enzyme that catalyses the first and the rate-limiting step in the catabolism of uracil, thymine and the analogue 5-fluorouracil. To date, more than 30 patients have been diagnosed with a complete enzyme deficiency. Here, we describe the fifth case with a complete DPD deficiency presenting at birth with severe neurological abnormalities. The patient was homozygous for the common splice-site mutation IVS14+1G > A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151913     DOI: 10.1007/s10545-005-4218-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  5 in total

1.  Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenase deficiency due to homozygosity for the C29R mutation.

Authors:  A B Van Kuilenburg; P Vreken; D Riva; G Botteon; N G Abeling; H D Bakker; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

2.  Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.

Authors:  S K Wadman; R Berger; M Duran; P K de Bree; S A Stoker-de Vries; F A Beemer; J J Weits-Binnerts; T J Penders; J K van der Woude
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

3.  Dihydropyrimidine dehydrogenase deficiency--a further case.

Authors:  B Wilcken; J Hammond; R Berger; G Wise; C James
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  Dihydropyrimidine dehydrogenase deficiency presenting with psychomotor retardation and ocular abnormalities.

Authors:  H D Bakker; M E Rubio Gozalbo; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 5.  Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency.

Authors:  A B Van Kuilenburg; P Vreken; N G Abeling; H D Bakker; R Meinsma; H Van Lenthe; R A De Abreu; J A Smeitink; H Kayserili; M Y Apak; E Christensen; I Holopainen; K Pulkki; D Riva; G Botteon; E Holme; M Tulinius; W J Kleijer; F A Beemer; M Duran; K E Niezen-Koning; G P Smit; C Jakobs; L M Smit; A H Van Gennip
Journal:  Hum Genet       Date:  1999-01       Impact factor: 4.132

  5 in total
  4 in total

1.  Targeted exome sequencing of suspected mitochondrial disorders.

Authors:  Daniel S Lieber; Sarah E Calvo; Kristy Shanahan; Nancy G Slate; Shangtao Liu; Steven G Hershman; Nina B Gold; Brad A Chapman; David R Thorburn; Gerard T Berry; Jeremy D Schmahmann; Mark L Borowsky; David M Mueller; Katherine B Sims; Vamsi K Mootha
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

2.  Neurotrophic keratitis in a patient with dihydroxypyrimidine dehydrogenase deficiency.

Authors:  Bharat Kapoor; Ezzedin A Luhishi; Andrew K K Chung; Jakobus C Pauw
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

3.  All You Need to Know About DPYD Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide.

Authors:  Federico Innocenti; Sarah C Mills; Hanna Sanoff; Joseph Ciccolini; Heinz-Josef Lenz; Gerard Milano
Journal:  JCO Oncol Pract       Date:  2020-11-16

Review 4.  SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.

Authors:  Raffaele Palmirotta; Claudia Carella; Erica Silvestris; Mauro Cives; Stefania Luigia Stucci; Marco Tucci; Domenica Lovero; Franco Silvestris
Journal:  Oncotarget       Date:  2018-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.